Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Produces cystine arylamidase.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (McLauchlin2011Bergey), clinical sources, food and the environment
DNA G+C(%): 36-38
|
Low T(℃): 4(+)
Mid T(℃): 38(+)
NaCl >6%: 10(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: Sens
oxacillin: Res
penicillin: Res
|
cefaclor: R(MIC50): 32, MIC90: >64, RNG: (16->64)
cefixime: R(MIC50): >64, MIC90: >64, RNG: (>64-)
cefoperazone: R(MIC50): 32, MIC90: >64, RNG: (2->64)
cefprozil: Var(MIC50): 2, MIC90: 8, RNG: (1-8)
cefuroxime: R(MIC50): 32, MIC90: >64, RNG: (1->64)
|
gentamicin: Sens
streptomycin: Sens
|
quin-dalf: Sens
|
linezolid: Sens
ciprofloxacin: Sens
levofloxacin: Sens
moxifloxacin: Sens
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Sens
|
teicoplanin: Sens
vancomycin: Sens
|
rifampicin: Sens
|
|
clindamycin: Sens
|